Fat Injection Major — Cost, Top Hospitals & Success Rates | MyMedicPlus

Major fat injection, also known as autologous fat grafting, autologous fat transfer, or lipofilling, is a surgical technique in which the patient's own adipose tissue (fat) is harvested by liposuction from donor sites with excess fat (typically the abdomen, flanks, thighs, or inner knees), processed to concentrate viable adipocytes and stromal vascular fraction (SVF), and then re-injected in multiple small aliquots into areas requiring volume augmentation, defect filling, or tissue regeneration. The procedure uses entirely natural, biocompatible tissue—the patient's own fat—eliminating the risks of rejection or allergic reaction associated with synthetic implants.

Autologous fat grafting has expanded significantly in scope over the past two decades, driven by growing understanding of the regenerative properties of adipose tissue. The stromal vascular fraction within fat contains adipose-derived stromal/stem cells (ADSCs) with paracrine regenerative effects that promote angiogenesis, reduce fibrosis, improve skin quality, and enhance wound healing. This regenerative component—beyond simple volumetric fill—explains why fat grafting improves skin texture, reduces scar contracture, and has shown promise in treating radiation-damaged tissue.

Procedure planning includes donor site selection, volume estimation, and injection site design. Fat is harvested using low-pressure liposuction to minimise adipocyte damage, processed by centrifugation (Coleman technique) or filtration, and injected through small blunt-tip cannulas in threading passes of 0.1 ml increments per pass—a critical technique point that ensures each fat droplet is surrounded by vascularised tissue, maximising contact with recipient blood supply for graft take.

Major fat grafting is used for breast reconstruction—as an adjunct to implant-based reconstruction to camouflage rippling and improve contour, and as a definitive autologous technique (multiple sessions of fat grafting replacing implant reconstruction in some patients). Breast augmentation with fat alone provides 1–2 cup size increase for patients preferring a natural, tactile alternative to implants. Post-mastectomy radiation sequelae—thin, contracted, irradiated tissue—is significantly improved by serial fat grafting sessions utilising the regenerative ADSC component.

Facial rejuvenation fat grafting restores age-related volume loss in the temples, tear troughs, nasolabial folds, cheeks, and lips, often combined with facelift surgery for comprehensive rejuvenation. Buttock augmentation (Brazilian Butt Lift—BBL) uses large-volume fat transfer to the gluteal region. Contour deformities after liposuction, trauma, or surgical resection are corrected with targeted fat grafting. Radiation-induced fibrosis in the breast, neck, or pelvis is treated with repeated fat grafting sessions. Hand rejuvenation addresses tendon and bone visibility in ageing hands. Lipedema-related soft tissue defects and HIV-associated facial lipoatrophy are treated with fat grafting.

Ideal candidates for major fat grafting are adults in good general health who have adequate donor fat available (BMI typically above 22 for facial grafting, higher for large-volume procedures), a specific volume deficit or contour deformity amenable to fat injection, and realistic expectations about graft survival—typically 50–70% of injected volume survives at 12 months, so slight overcorrection is planned at surgery. Patients considering BBL must have sufficient gluteal and donor site anatomy to achieve meaningful augmentation.

Contraindications include severe systemic illness precluding surgery, coagulation disorders, active infection at donor or recipient sites, very low BMI with insufficient donor fat, and active cancer with potential for tumour cell contamination (theoretical concern for cancer patients). Smoking significantly reduces fat graft survival and is a relative contraindication. Patients with active autoimmune conditions affecting wound healing, and those taking immunosuppressants, may have impaired fat graft integration. The Brazilian Butt Lift specifically requires careful pre-operative planning with experienced surgeons due to the significant risk of fatal fat embolism from inadvertent intramuscular injection.

Fat harvest uses low-pressure liposuction with blunt-tip Tulip or Byron infiltration cannulas under tumescent local anaesthesia, minimising trauma to fragile adipocytes. The Coleman centrifugation technique (1,200 rpm for 3 minutes) is most widely used, separating usable fat from blood, oil, and infiltrate. Alternative processing includes filtration (Puregraft system), mechanical emulsification for regenerative fat, and nanofat preparation (emulsified fat injected through fine needles for skin quality improvement rather than volume).

Injection technique is critical to graft survival: fat is injected in multiple passes using small-bore blunt cannulas (1–2 mm), depositing 0.1–0.2 ml aliquots per pass in multiple planes (subcutaneous, submuscular, intramuscular for BBL—though intramuscular BBL carries the highest embolism risk). The BRAVA external tissue expansion system, worn for weeks before surgery, is used in some breast augmentation programmes to pre-expand the recipient site and increase engraftment capacity. Stem cell-enhanced fat grafting (SVF enrichment or concentrated ADSC addition) is offered at specialist centres to improve graft retention, though evidence for superior clinical benefit over standard Coleman grafting remains mixed. Shared decision-making between the patient and specialist ensures the chosen modality aligns with individual anatomy, comorbidities, risk tolerance, and personal goals. A formal consultation with a board-certified specialist, review of pre-treatment imaging or investigation results, and multidisciplinary team input for complex cases are standard practice before finalising the treatment plan.

Published systematic reviews document fat graft survival rates of 40–80% at 12 months depending on technique, recipient site, and patient characteristics. With the planned over-correction technique, final volume outcomes meet patient expectations in the majority of cases. Breast reconstruction with fat grafting achieves natural feel and appearance without the risks of implant-associated complications. Facial fat grafting achieves soft, natural volumetric correction of hollowing and deflation that persists for many years—unlike temporary fillers, results are largely permanent after initial settling.

The regenerative effects of fat grafting on skin quality, radiation fibrosis, and scar contracture are well-documented. Studies in post-mastectomy radiation patients show significant improvement in skin pliability, range of motion, and quality of life after serial fat grafting. Brazilian Butt Lift achieves safe gluteal augmentation in appropriately selected patients at accredited centres following ISAPS safety guidelines; mortality rates are estimated at 1:3,000 to 1:6,000 at high-volume specialised centres compared to 1:1,000 at low-volume facilities.

Fat resorption is the most predictable complication: 30–50% of injected fat is reabsorbed in the first 3–6 months, requiring repeat sessions to achieve desired volume. Oil cysts—firm benign cystic areas from liquefied fat—occur in 5–10% of patients, particularly with large-volume injections, and occasionally require aspiration. Calcification of residual fat occurs over years and may complicate mammographic interpretation in breast fat grafting, though it is distinguishable from malignant calcification in experienced hands. Infection at injection sites (1–3%) and haematoma at donor or recipient sites are uncommon.

The Brazilian Butt Lift carries a specific risk of pulmonary fat embolism—the leading cause of aesthetic surgery-related death—from inadvertent injection into gluteal veins or intramuscular injection. ISAPS safety guidelines mandate deep fat injection into the subcutaneous plane only (never intramuscular), real-time ultrasound guidance, and cannula positioning verification. The estimated mortality risk is 1:3,000–6,000 in high-volume centres following current safety protocols. Breast fat grafting: theoretical concern about stimulation of occult malignancy from ADSC growth factors exists; comprehensive evidence to date does not support increased breast cancer risk, but long-term studies are ongoing.

Post-operative recovery after major fat grafting involves donor site management (compression garments for 4–6 weeks to minimise seroma and promote skin retraction) and recipient site protection (avoiding pressure on fat-injected areas for 4–6 weeks—particularly important for BBL patients who must avoid sitting directly on the buttocks). Swelling and bruising resolve over 2–4 weeks, and final results are assessed at 3–6 months when graft remodelling is complete.

Most patients return to light activities within 1–2 weeks and resume normal exercise at 4–6 weeks. Repeat fat grafting sessions—typically at 6-month intervals—may be required to achieve target volume, particularly for breast augmentation programs requiring 3–4 sessions. Post-procedure mammography after breast fat grafting is performed annually to establish new baselines and detect fat-related calcifications that require radiological review. Follow-up at 3 months, 6 months, and annually allows volume assessment and planning of any additional sessions.

In the United States, major fat grafting costs USD 5,000–15,000 depending on volume and sites, including liposuction harvest, processing, and injection under sedation or general anaesthesia. Brazilian Butt Lift costs USD 8,000–20,000 at established US centres. Breast augmentation with fat grafting requires multiple sessions at USD 5,000–10,000 each. Facial fat grafting combined with facelift adds USD 2,000–5,000 to the surgical cost. In the UK, fat grafting procedures cost GBP 3,000–10,000 at private hospitals.

India offers major fat grafting procedures at significantly lower cost: BBL at USD 3,000–7,000; facial fat grafting at USD 1,000–3,000; breast fat grafting at USD 2,000–6,000 per session. Thailand provides comparable procedures at USD 2,500–8,000. Turkey is a popular destination for fat grafting combined with liposuction at USD 2,000–6,000. Patients travelling for BBL surgery should research the safety record of the centre and confirm that surgeons follow current ISAPS safety guidelines for intragluateal injection technique.

Injectable dermal fillers (hyaluronic acid, calcium hydroxyapatite, poly-L-lactic acid) provide temporary volumetric correction of facial deflation without surgery, lasting 12–18 months. They are appropriate for patients not ready for or not suitable for fat grafting. Permanent synthetic fillers (PMMA-based) offer lasting augmentation but carry risks of granuloma and migration, and are less favoured in modern practice. Silicone implants (facial, breast, buttock) provide definitive permanent augmentation in a single procedure, without the graft survival variability of fat, but involve the implant-related risks of capsular contracture, migration, and infection.

For breast reconstruction, implant-based reconstruction provides an immediately definitive result in a single or staged procedure. The TRAM flap, DIEP flap, and other pedicled or free autologous breast reconstruction techniques offer superior natural results without fat resorption variability, at the cost of greater donor site morbidity. Each approach has specific advantages depending on patient anatomy, cancer treatment history, and personal preferences.